ABBV · Earnings call · 2026Q3T · Full report

Litigation and Legal Risk

AbbVie Inc. · 2026-10-30 · Importance 53 · Surprise 60

AbbVie argued that Botox is excluded from selection under the Inflation Reduction Act because one of its three ingredients is human serum albumin, a protein extracted from human blood plasma. The company said Botox contains 100,000 times more human serum albumin than toxin. A federal district court ruled in AbbVie’s favor on October 29, 2026, but the ruling may be appealed by the government. AbbVie said it does not expect a price to be published while the proceedings continue.

Key facts

• A Federal District Court ruled in AbbVie’s favor on the day before the October 30, 2026 call regarding whether Botox is eligible for IRA drug-price selection.
• The government may appeal the Botox IRA ruling, and AbbVie said further proceedings remain possible.